Skip to main content
Top
Published in: Journal of Cancer Survivorship 1/2019

01-02-2019

Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors

Authors: Alison Pearce, Bianca Tomalin, Billingsley Kaambwa, Nicole Horevoorts, Saskia Duijts, Floortje Mols, Lonneke van de Poll-Franse, Bogda Koczwara

Published in: Journal of Cancer Survivorship | Issue 1/2019

Login to get access

Abstract

Purpose

The aim of this study was to examine the relationship between employment and financial toxicity by examining the prevalence of, and factors associated with, financial toxicity among cancer survivors.

Methods

We conducted a secondary analysis of a sub-sample from the Dutch Patient Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship (PROFILES) registry. Descriptive statistics, bivariate analysis and logistic regression were used.

Results

A total of 2931 participants with diverse cancer types were included in the analysis with a mean age of 55 years (range 18 to 65). Nearly half (49%) of participants were employed at the time of the survey, and 22% reported financial toxicity. Those who were not employed were at greater risk of financial toxicity (27% vs 16%, p < 0.001), and this did not vary according to time since diagnosis. The odds of reporting financial toxicity were greater for participants who were male, younger, unmarried, with low education, low socioeconomic status, or without paid employment. Those with basal cell carcinoma had lower risk of financial toxicity, while those with haematological or colorectal cancer had highest risk of financial toxicity.

Conclusions

This research confirms that unemployment is significantly associated with financial toxicity and that those with limited financial resources are most at risk.

Implications for cancer survivors

Increased awareness of financial toxicity and its associated factors among clinicians may result in improved screening and appropriate referrals for support services. The implementation of effective multidisciplinary return to work interventions, as part of standard cancer survivorship care, may reduce financial toxicity among cancer survivors.
Literature
1.
go back to reference de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araújo FS, Hlubocky FJ, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (COST). Cancer. 2017;123:476–84.CrossRefPubMed de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araújo FS, Hlubocky FJ, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (COST). Cancer. 2017;123:476–84.CrossRefPubMed
2.
go back to reference Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among Cancer survivors: we Can’t pay the co-pay. Patient - Patient-Centered Outcomes Res. 2017;10:295–309.CrossRef Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among Cancer survivors: we Can’t pay the co-pay. Patient - Patient-Centered Outcomes Res. 2017;10:295–309.CrossRef
3.
go back to reference Currow D, Aranda S. Financial toxicity in clinical care today: a “menu without prices”1. Med J Aust. 2016;204:397.CrossRefPubMed Currow D, Aranda S. Financial toxicity in clinical care today: a “menu without prices”1. Med J Aust. 2016;204:397.CrossRefPubMed
4.
go back to reference Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public–private healthcare system. Support Care Cancer. 2013;21:107–17.CrossRefPubMed Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public–private healthcare system. Support Care Cancer. 2013;21:107–17.CrossRefPubMed
5.
go back to reference Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer treatment in Ontario. Canada Support Care Cancer. 2006;14:1077–85.CrossRefPubMed Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer treatment in Ontario. Canada Support Care Cancer. 2006;14:1077–85.CrossRefPubMed
6.
go back to reference Spelten ER, Sprangers MAG, Verbeek JHAM. Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology. 2002;11:124–31.CrossRefPubMed Spelten ER, Sprangers MAG, Verbeek JHAM. Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology. 2002;11:124–31.CrossRefPubMed
7.
go back to reference Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109–30.CrossRefPubMed Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109–30.CrossRefPubMed
8.
go back to reference Guy GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31:3749–57.CrossRefPubMedPubMedCentral Guy GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31:3749–57.CrossRefPubMedPubMedCentral
9.
go back to reference Taskila T, Lindbohm ML. Factors affecting cancer survivors’ employment and work ability. Acta Oncol Stockh Swed. 2007;46:446–51.CrossRef Taskila T, Lindbohm ML. Factors affecting cancer survivors’ employment and work ability. Acta Oncol Stockh Swed. 2007;46:446–51.CrossRef
10.
go back to reference Kale HP, Carroll NV. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer. 2016;122:283–9.CrossRefPubMed Kale HP, Carroll NV. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer. 2016;122:283–9.CrossRefPubMed
11.
go back to reference Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, et al. Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract. 2014;10:332–8.CrossRefPubMed Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, et al. Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract. 2014;10:332–8.CrossRefPubMed
12.
go back to reference Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18:381–90.CrossRefPubMedPubMedCentral Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18:381–90.CrossRefPubMedPubMedCentral
14.
go back to reference Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncol Williston Park N. 2013;27:80–149. Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncol Williston Park N. 2013;27:80–149.
15.
go back to reference van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47:2188–94.CrossRefPubMed van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47:2188–94.CrossRefPubMed
16.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRef
17.
go back to reference Field, A. Discovering statistics with SPSS. 3rd ed. London: Sage Publications Ltd; Field, A. Discovering statistics with SPSS. 3rd ed. London: Sage Publications Ltd;
18.
go back to reference Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2:e408–16.CrossRefPubMed Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2:e408–16.CrossRefPubMed
19.
go back to reference Schoen C, Osborn R, Squires D, Doty MM. Access, affordability, and insurance complexity are often worse in the United States compared to ten other countries. Health Aff Proj Hope. 2013;32:2205–15.CrossRef Schoen C, Osborn R, Squires D, Doty MM. Access, affordability, and insurance complexity are often worse in the United States compared to ten other countries. Health Aff Proj Hope. 2013;32:2205–15.CrossRef
20.
go back to reference Hounshell J, Tomori C, Newlin R, Knox K, Rundhaugen L, Tallman M, et al. Changes in finances, insurance, employment, and lifestyle among persons diagnosed with hairy cell leukemia. Oncologist. 2001;6:435–40.CrossRefPubMed Hounshell J, Tomori C, Newlin R, Knox K, Rundhaugen L, Tallman M, et al. Changes in finances, insurance, employment, and lifestyle among persons diagnosed with hairy cell leukemia. Oncologist. 2001;6:435–40.CrossRefPubMed
21.
go back to reference Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:1608–14.CrossRef Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:1608–14.CrossRef
22.
go back to reference Amir Z, Brocky J. Cancer survivorship and employment: epidemiology. Occup Med Oxf Engl. 2009;59:373–7.CrossRef Amir Z, Brocky J. Cancer survivorship and employment: epidemiology. Occup Med Oxf Engl. 2009;59:373–7.CrossRef
23.
go back to reference Gordon LG, Beesley VL, Lynch BM, Mihala G, McGrath C, Graves N, et al. The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study. BMC Public Health. 2014;14:963.CrossRefPubMedPubMedCentral Gordon LG, Beesley VL, Lynch BM, Mihala G, McGrath C, Graves N, et al. The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study. BMC Public Health. 2014;14:963.CrossRefPubMedPubMedCentral
24.
go back to reference Gordon LG, Beesley VL, Mihala G, Koczwara B, Lynch BM. Reduced employment and financial hardship among middle-aged individuals with colorectal cancer. Eur J Cancer Care (Engl). 2017;26. Gordon LG, Beesley VL, Mihala G, Koczwara B, Lynch BM. Reduced employment and financial hardship among middle-aged individuals with colorectal cancer. Eur J Cancer Care (Engl). 2017;26.
25.
go back to reference Zajacova A, Dowd JB, Schoeni RF, Wallace RB. Employment and income losses among cancer survivors: estimates from a national longitudinal survey of American families. Cancer. 2015;121:4425–32.CrossRefPubMedPubMedCentral Zajacova A, Dowd JB, Schoeni RF, Wallace RB. Employment and income losses among cancer survivors: estimates from a national longitudinal survey of American families. Cancer. 2015;121:4425–32.CrossRefPubMedPubMedCentral
26.
go back to reference de Boer AG, Taskila T, Tamminga SJ, Frings-Dresen MH, Feuerstein M, Verbeek JH. Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2011;CD007569. de Boer AG, Taskila T, Tamminga SJ, Frings-Dresen MH, Feuerstein M, Verbeek JH. Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2011;CD007569.
28.
go back to reference Tamminga SJ, de Boer AGEM, Verbeek JHA, Frings-Dresen MHW. Return-to-work interventions integrated into cancer care: a systematic review. Occup Environ Med. 2010;67:639–48.CrossRefPubMed Tamminga SJ, de Boer AGEM, Verbeek JHA, Frings-Dresen MHW. Return-to-work interventions integrated into cancer care: a systematic review. Occup Environ Med. 2010;67:639–48.CrossRefPubMed
Metadata
Title
Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors
Authors
Alison Pearce
Bianca Tomalin
Billingsley Kaambwa
Nicole Horevoorts
Saskia Duijts
Floortje Mols
Lonneke van de Poll-Franse
Bogda Koczwara
Publication date
01-02-2019
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-018-0723-7

Other articles of this Issue 1/2019

Journal of Cancer Survivorship 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine